Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Forte Biosciences, Inc. - Common Stock
(NQ:
FBRX
)
76.78
-0.09 (-0.12%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 12, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Forte Biosciences, Inc. - Common Stock
< Previous
1
2
3
4
5
6
Next >
Forte Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forte Biosciences, Inc. - FBRX
August 11, 2026
From
Kahn Swick & Foti, LLC
Via
Business Wire
FBRX Stock Alert: Halper Sadeh LLC is Investigating Whether Forte Biosciences, Inc. is Obtaining a Fair Price for its Shareholders
August 08, 2026
From
Halper Sadeh LLC
Via
Business Wire
Halper Sadeh LLC is Investigating Whether FBRX, LXFR, SMTI, MKTX are Obtaining Fair Deals for their Shareholders
August 05, 2026
From
Halper Sadeh LLC
Via
GlobeNewswire
Halper Sadeh LLC is Investigating Whether FBRX and SAFT are Obtaining Fair Deals for their Shareholders
July 28, 2026
From
Halper Sadeh LLC
Via
GlobeNewswire
Forte Biosciences Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forte Biosciences, Inc. - FBRX
July 28, 2026
From
Kahn Swick & Foti, LLC
Via
Business Wire
Which stocks are moving on Monday?
↗
July 27, 2026
Via
Chartmill
Monday's session: top gainers and losers
↗
July 27, 2026
Via
Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
July 27, 2026
Via
Chartmill
FBRX Stock Alert: Halper Sadeh LLC is Investigating Whether Forte Biosciences, Inc. is Obtaining a Fair Price for its Shareholders
July 27, 2026
From
Halper Sadeh LLC
Via
Business Wire
These stocks that are showing activity before the opening bell on Monday.
↗
July 27, 2026
Via
Chartmill
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
July 27, 2026
Gainers Matinas BioPharma Hldgs (AMEX:MTNB) shares increased by 59.7% to $0.39 during Monday's pre-market session. The company's market cap stands at $1.5 million. Forte Biosciences (NASDAQ:FBRX) stock...
Via
Benzinga
argenx to Acquire Forte Biosciences, Inc., Adding First-in-Class Anti-CD122 Antibody, FB102, to Its Immunology Pipeline
July 27, 2026
From
Forte Biosciences, Inc.
Via
Business Wire
Top movers analysis one hour before the close of the markets on 2026-07-10: top gainers and losers in today's session.
↗
July 10, 2026
Via
Chartmill
12 Health Care Stocks Moving In Friday's Intraday Session
↗
July 10, 2026
Gainers EUDA Health Holdings (NASDAQ:EUDA) shares rose 22.3% to $15.2 during Friday's regular session. Forte Biosciences (NASDAQ:FBRX) shares moved upwards by 18.39% to $43.45. The market value of...
Via
Benzinga
Forte Biosciences' FB102 Hits Key Goal in Vitiligo Study, Shows Durable Improvement
↗
July 10, 2026
Forte Biosciences (NASDAQ:FBRX) said FB102 showed statistically significant improvement in a small placebo-controlled vitiligo study, with Chief Executive Officer Paul Wagner highlighting continued...
Via
MarketBeat
Which stocks are experiencing notable movement on Thursday?
↗
July 09, 2026
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
July 09, 2026
Gainers Virax Biolabs Group (NASDAQ:VRAX) shares rose 178.9% to $8.87 during Thursday's regular session. The market value of their outstanding shares is at $2.5 million. Forte Biosciences (NASDAQ:FBRX)...
Via
Benzinga
Let's take a look at the stocks that are in motion in today's session.
↗
July 09, 2026
Via
Chartmill
FB102 Achieves Statistically Significant Improvement in Vitiligo at Week 24 After Completion of 12-Week Treatment Period
July 09, 2026
From
Forte Biosciences, Inc.
Via
Business Wire
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
May 11, 2026
From
Forte Biosciences, Inc.
Via
Business Wire
Forte Biosciences, Inc. Announces First Quarter 2026 Results and Provides Update
May 11, 2026
From
Forte Biosciences, Inc.
Via
Business Wire
Which stocks are experiencing notable movement on Thursday?
↗
April 09, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
April 09, 2026
Via
Chartmill
Forte Biosciences Announces Pricing of $150 Million Public Offering
April 08, 2026
From
Forte Biosciences, Inc.
Via
Business Wire
Forte Biosciences Announces Proposed Public Offering
April 08, 2026
From
Forte Biosciences, Inc.
Via
Business Wire
Forte Biosciences, Inc. Announces 2025 Results and Provides Update
March 31, 2026
From
Forte Biosciences, Inc.
Via
Business Wire
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
March 17, 2026
From
Forte Biosciences, Inc.
Via
Business Wire
Forte Biosciences, Inc. Reports Inducement Grants Under NASDAQ Listing Rules
March 04, 2026
From
Forte Biosciences, Inc.
Via
Business Wire
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
February 09, 2026
From
Forte Biosciences, Inc.
Via
Business Wire
Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules
December 22, 2025
From
Forte Biosciences, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit